| 1 |
Localized only (localized, NOS)
- MFCG Stage I
+ Less than 10% of skin surface, no tumors
+ Limited to patches, papules, or plaques
- MFCG Stage II
+ Greater than or equal to 10% of skin surface, no tumors
+ Generalized patches, papules, or plaques
- Not stated whether patches, papules, or plaques
+ % of body surface not stated, no tumors
+ Skin involvement, NOS: extent not stated, no tumors |
| 2 |
Regional by direct extension only
- MFCG Stage III
+ Cutaneous tumor, size not stated
+ Generalized erythroderma (confluence of erythemia)
* (greater than 50% of body involved with diffuse redness)
+ One or more tumors equal to 1 cm or greater
+ Sezary syndrome
+ Skin lesion described as tumor less than 1 cm |
| 3 |
Regional lymph node(s) involved only
- Both clinically enlarged palpable lymph node(s) (adenopathy) AND
+ pathologically positive nodes
- Clinically enlarged palpable lymph node(s) (adenopathy) AND
+ either pathologically negative nodes or no pathological statement
- No clinically enlarged palpable lymph node(s) (adenopathy) BUT
+ pathologically positive lymph node(s)
- Dutch grade 1-4 OR NCI LN 0-4
+ Clone positive, negative or unknown
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
| 4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
| 7 |
Distant site(s) involved
- Distant site(s) (including further contiguous extension)
+ MFCG Stage IV
* Bone marrow
* Involvement by at least one organ outside the skin, nodes, blood, or bone marrow
* Liver
* Spleen
* Visceral (non-cutaneous, extranodal) involvement, pathologically confirmed
- Distant metastasis, NOS
+ Carcinomatosis |
| 9 |
Unknown if extension or metastasis |
